Cost effectiveness analysis in health care: contraindications

被引:68
作者
Donaldson, C [1 ]
Currie, G
Mitton, C
机构
[1] Univ Newcastle Upon Tyne, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Business, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB 52N 4N1, Canada
[4] Univ Calgary, Dept Econ, Calgary, AB 52N 4N1, Canada
[5] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB T2N 1N4, Canada
来源
BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7369期
关键词
D O I
10.1136/bmj.325.7369.891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In economic evaluation of healthcare interventions, the dominant practice is to calculate an incremental cost effectiveness ratio, usually based on the comparison of a new intervention against current practice. Canadian and UK health economists question the economic foundations of such an approach.
引用
收藏
页码:891 / 894
页数:4
相关论文
共 25 条
[1]  
Donaldson C, 1996, HEALTH ECON, V5, P267, DOI 10.1002/(SICI)1099-1050(199605)5:3<267::AID-HEC209>3.0.CO
[2]  
2-X
[3]   Guidelines for authors and peer reviewers of economic submissions to the BMJ [J].
Drummond, MF ;
Jefferson, TO .
BRITISH MEDICAL JOURNAL, 1996, 313 (7052) :275-283
[4]   Screening for hereditary hemochromatosis in siblings and children of affected patients - A cost-effectiveness analysis [J].
El-Serag, HB ;
Inadomi, JM ;
Kowdley, KV .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (04) :261-+
[5]   The cost effectiveness of combination antiretroviral therapy for HIV disease. [J].
Freedberg, KA ;
Losina, E ;
Weinstein, MC ;
Paltiel, AD ;
Cohen, CJ ;
Seage, GR ;
Craven, DE ;
Zhang, H ;
Kimmel, AD ;
Goldie, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :824-831
[6]  
GAFNI A, 1993, CAN MED ASSOC J, V148, P913
[7]   Twenty years of health care economic analysis in Spain:: Are we doing well? [J].
García-Altés, A .
HEALTH ECONOMICS, 2001, 10 (08) :715-729
[8]  
GOLD MR, 2001, PHARMACOECONOMICS, V19, P609
[9]   Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis [J].
Gould, MK ;
Dembitzer, AD ;
Sanders, GD ;
Garber, AM .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (10) :789-+
[10]   The influence of economic evaluation studies on decision making. A European survey [J].
Hoffmann, C ;
von der Schulenburg, JMG .
HEALTH POLICY, 2000, 52 (03) :179-192